A to Z Summary Results - Patient Decision Aids - Ottawa Hospital Research Institute 


Decision Aid Summary

Title A decision aid to facilitate shared decision making for adults newly diagnosed with attention-deficit hyperactivity disorder.
To access it Click here to view the decision aid on the developer website
Audience Adults newly diagnosed with attention-deficit hyperactivity disorder.
Options included In addition to coping strategies, taking or not taking medication.
(If taking medication) Options for medication:
Methylphenidate hydrochloride extended-release tablets,
Lisdexamfetamine mesylate,
Atomoxetine hydrochloride,
Guanfacine hydrochloride.
Year of last update or review 2024
Format Web, PDF
Developer Yumi Aoki
Where was it developed? yumiaoki@slcn.ac.jp
St .Luke's International University
Japan
Health condition Attention Deficit Hyperactivity Disorder
Type of decision aid Treatment
Language Japanese
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
7 out of 7 criteria to be defined as a patient decision aid
7 out of 8 criteria to lower the risk of making a biased decision
Not applicable: other criteria for decision aids about screening or testing

Last modified: 2024-03-04.